Pulmonary Hypertension that Developed During Treatment for Hepatopulmonary Syndrome and Pulmonary Arteriovenous Malformation
-
- Ikubo Yumiko
- Department of Respirology, Graduate School of Medicine, Chiba University, Japan
-
- Kasai Hajime
- Department of Respirology, Graduate School of Medicine, Chiba University, Japan
-
- Sugiura Toshihiko
- Department of Respirology, Graduate School of Medicine, Chiba University, Japan
-
- Saito Takahiko
- Department of Medicine, School of Medicine, Chiba University, Japan
-
- Shoji Hiroki
- Department of Respirology, Graduate School of Medicine, Chiba University, Japan
-
- Sakao Seiichiro
- Department of Respirology, Graduate School of Medicine, Chiba University, Japan
-
- Kasahara Yasunori
- Department of Respirology, Graduate School of Medicine, Chiba University, Japan Department of Respiratory Medicine, Eastern Chiba Medical Center, Japan
-
- Tanabe Nobuhiro
- Department of Respirology, Graduate School of Medicine, Chiba University, Japan
-
- Tatsumi Koichiro
- Department of Respirology, Graduate School of Medicine, Chiba University, Japan
この論文をさがす
抄録
<p>Hepatopulmonary syndrome (HPS) and pulmonary arteriovenous malformation (PAVM) are hypoxemic diseases caused by right-to-left shunting but are rarely concomitant with pulmonary hypertension (PH). A 66-year-old woman with chronic hepatitis C was scheduled to undergo liver transplantation. She was referred to our department for hypoxia and an abnormal shadow in the right lung found on a preoperative examination. She was diagnosed with HPS and a PAVM in the right middle lobe. After liver transplantation, PH temporarily developed, but the pulmonary arterial pressure normalized after coil embolization. Combined HPS and PAVM may cause unique changes in pulmonary hemodynamics during treatment. </p>
収録刊行物
-
- Internal Medicine
-
Internal Medicine 58 (12), 1765-1769, 2019-06-15
一般社団法人 日本内科学会